New hope could be on the horizon for ALS patients in the form of a “breakthrough" drug, researchers say. Neuvivo is seeking ...
The FDA has accepted a new drug application for the intravesical solution of UGN-102 in low-grade intermediate-risk ...
Zacks.com on MSN2d
Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug LumryzAvadel Pharmaceuticals plc AVDL announced that the FDA has approved its supplemental new drug application (sNDA) seeking ...
In its new drug application, Stealth BioTherapeutics described elamipretide as a first-in-class mitochondrial protective ...
Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. But with ...
A slate of popular policies commonly bandied about to help reduce drug costs would each cut average prices by only a handful of percentage points, according to a recent Congressional Budget Office ...
KT-621 has demonstrated dupilumab-like activity and was well tolerated ina wide variety of preclinical models of TH2 diseasesKT-621 is expected ...
Diet and diabetes drugs like Ozempic and Mounjaro could also help people struggling with alcohol and opioid abuse, according ...
PDUFA goal date set for June 13, 2025 UGN-102 would be the first FDA-approved medicine for LG-IR-NMIBC, if approved "The FDA acceptance of our NDA is a pivotal moment in our journey to bring UGN ...
Pharmaceutical Technology on MSN5d
Bayer applies for EU approval of menopause drug elinzanetantBayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief ...
AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...
After two previous failed attempts with the FDA, AbbVie now has one more offering in its lineup — a critical step as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback